Interstitial Cystitis Clinical Trial
Official title:
A Double-Blind, Randomized Study of Puncturing Versus Non-Puncturing Acupuncture for the Treatment of Interstitial Cystitis Symptoms
Acupuncture is a form of Chinese medicine that has been in existence for more than a
thousand years. This clinical trial performs two types of acupuncture on traditional
'bladder' points to determine if one type demonstrates improvement over the other. In the
first type needles stimulate acupuncture points on the skin, and in the second type the
needles penetrate through the skin similar to how acupuncture is usually performed. The
technique is done through shields so that people will not know what type of acupuncture they
receive.
Patients must have at least moderately severe disease as determined by a urologist. They
must be willing not to change their medical regimen for the duration of the trial. Patients
will receive twelve treatments over six to twelve weeks. They will be asked to fill out
symptom questionnaires and bladder diaries at regular intervals to monitor change. All
treatment is free of charge, and patients who complete the trial will receive a small
stipend.
Patients eligible for enrollment include:
- Age 18-65 years
- Symptomatic IC for at least six months
- Urinary frequency of at least eleven voids in a 24 hour period
- A self-rated global discomfort score of 4 or greater on a 0-10 scale
Patients may not be enrolled who have a history of chronic bladder disease or pelvic disease
including cancer, calculi, infection or complications of nervous system disease or diabetes.
They must be on no blood thinning agents or have had any recent medication changes or
bladder procedures.
After screening physical examination and history-taking, patients will be asked to fill out
standard symptom questionnaires. They will be given a bladder diary to fill out for the 24
hours prior to their first acupuncture treatment which will be scheduled within a week.
Patients will be asked to return from once- to twice-weekly for a total of twelve
treatments. Patients will complete a bladder diary before each treatment and a questionnaire
form before every other visit. The same questionnaire will be used at the exit interview
after the last treatment, and a final time four weeks after the last treatment. This is
because we are interested in the duration of potential benefit from acupuncture treatment.
Patients will be randomly assigned to one of two groups. All acupuncture will be performed
through plastic shields so that the patient does not know which group he or she has been
assigned to. In the first type of acupuncture, retractable needles are used such that the
patient feels a pin sensation but there is no penetration of the epidermis. In the second
type, non-retractable needles penetrate the acupuncture points into deeper tissue. It is not
known whether deeper penetration is required for acupuncture to work, or if acupuncture is
of benefit at all for this condition.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04313972 -
IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone
|
Phase 4 | |
Completed |
NCT03282318 -
A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis
|
Phase 2 | |
Completed |
NCT03463499 -
The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients
|
N/A | |
Completed |
NCT02898220 -
Trans-MAPP II Study of Urologic Chronic Pelvin Pain
|
||
Terminated |
NCT02591199 -
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
|
Phase 2 | |
Completed |
NCT02247557 -
Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis
|
Phase 2 | |
Active, not recruiting |
NCT01731470 -
Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
|
N/A | |
Completed |
NCT01197261 -
OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)
|
Phase 2 | |
Completed |
NCT00971568 -
Urinary Biomarkers Characteristic to Interstitial Cystitis
|
N/A | |
Completed |
NCT00527917 -
A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.
|
Phase 2 | |
Completed |
NCT00150488 -
URACYST® For the Treatment of GAG Deficient Interstitial Cystitis
|
N/A | |
Terminated |
NCT00086684 -
Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis
|
Phase 4 | |
Recruiting |
NCT04845217 -
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
|
Phase 1/Phase 2 | |
Completed |
NCT04401176 -
Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome
|
Phase 2 | |
Recruiting |
NCT05147779 -
Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis
|
Phase 1 | |
Suspended |
NCT04450316 -
Low-dose Naltrexone for Bladder Pain Syndrome
|
Phase 2 | |
Completed |
NCT04010513 -
Hypnosis for Bladder Pain Syndrome
|
N/A | |
Completed |
NCT05179460 -
A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy
|
||
Completed |
NCT02232282 -
Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial
|
N/A | |
Completed |
NCT00546858 -
Relationship of Interstitial Cystitis to Vulvodynia
|
N/A |